Wnt-5a expression in breast carcinomas - Differences between in-situ and invasive disease

被引：0
|
作者：
Dhillon, J [1 ]
Walker, RA [1 ]
机构：
[1] Univ Leicester, Leicester LE1 7RH, Leics, England
来源：
JOURNAL OF PATHOLOGY | 2004年 / 204卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：13A / 13A
页数：1
相关论文
共 50 条
  • [21] Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas
    Vakkala, M
    Kahlos, K
    Lakari, E
    Pääkkö, P
    Kinnula, V
    Soini, Y
    CLINICAL CANCER RESEARCH, 2000, 6 (06) : 2408 - 2416
  • [22] Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast
    Sapino, A
    Bongiovanni, M
    Cassoni, P
    Righi, L
    Arisio, R
    Deaglio, S
    Malavasi, F
    JOURNAL OF PATHOLOGY, 2001, 194 (02): : 254 - 261
  • [23] CD31 expression by cells of extensive ductal in situ and invasive carcinomas of the breast
    A Sapino
    L Righi
    P Cassoni
    M Bongiovanni
    S Deaglio
    F Malavasi
    G Bussolati
    Breast Cancer Research, 3 (Suppl 1)
  • [24] Genetic differences between ductal carcinoma in situ and invasive breast cancer
    Allred, DC
    Tsimelzon, A
    Mohsin, SK
    Hilsenbeck, SG
    Medina, D
    Osborne, CK
    O'Connell, P
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S10 - S10
  • [25] Gene expression differences between paired primary and metastatic breast carcinomas
    Giri, D
    Donaton, M
    Olshen, A
    Panageas, K
    Lal, P
    Levcovici, S
    Brogi, E
    Hudis, C
    Van Zee, K
    Tan, L
    Gerald, W
    LABORATORY INVESTIGATION, 2003, 83 (01) : 29A - 29A
  • [26] Gene expression differences between paired primary and metastatic breast carcinomas
    Giri, D
    Donaton, M
    Olshen, A
    Panageas, K
    Lal, P
    Levcovici, S
    Brogi, E
    Hudis, C
    Van Zee, K
    Tan, L
    Gerald, W
    MODERN PATHOLOGY, 2003, 16 (01) : 29A - 29A
  • [27] Low expression of Wnt-5a gene is associated with high-risk neuroblastoma
    Blanc, E
    Le Roux, G
    Bénard, J
    Raguénez, G
    ONCOGENE, 2005, 24 (07) : 1277 - 1283
  • [28] Biological staging of incipient, in situ, and invasive breast carcinomas
    Querzoli, P
    Albonico, G
    Ferretti, S
    Rinaldi, R
    Nenci, I
    BASIS FOR CANCER MANAGEMENT, 1996, 784 : 381 - 394
  • [29] Decreased Expression Levels of Phosphorylated Ser239-Vasodilator-Stimulated Phosphoprotein Indicate Progression from In-Situ to Invasive Breast Carcinomas
    Cotzia, P.
    Bombonati, A.
    Ali, M.
    Palazzo, J. P.
    Birbe, R.
    Pitari, G.
    MODERN PATHOLOGY, 2013, 26 : 34A - 35A
  • [30] Decreased Expression Levels of Phosphorylated Ser239-Vasodilator-Stimulated Phosphoprotein Indicate Progression from In-Situ to Invasive Breast Carcinomas
    Cotzia, P.
    Bombonati, A.
    Ali, M.
    Palazzo, J. P.
    Birbe, R.
    Pitari, G.
    LABORATORY INVESTIGATION, 2013, 93 : 34A - 35A
12345